Home › Funds › Ascent Wealth Partners, LLC › ABT

Ascent Wealth Partners, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Ascent Wealth Partners, LLC reported holding 69,610 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$6.9M, representing 0.68% of its reported portfolio and ranking #46 among its reported holdings. Ascent Wealth Partners, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)69.61K sh
Reported value held$6.88M
Portfolio Weight0.68%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Ascent Wealth Partners, LLC's ABT position evolved

Ascent Wealth Partners, LLC first disclosed a stake in ABT in Q3 2023 at 96,256 shares (US$9.3M). The position peaked in Q1 2025 at 98,472 shares, worth US$13.1M. Across 13 filings, Ascent Wealth Partners, LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 69,610 shares valued at US$6.9M — an increase of 374 shares quarter over quarter.. Notable position changes include a 29% trim in Q1 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 96.26K $9.32M New
Q4 2023 96.30K $10.60M Hold
Q1 2024 97.12K $11.04M Add
Q2 2024 95.59K $9.93M Reduce
Q3 2024 94.46K $10.77M Reduce
Q4 2024 94.19K $10.65M Hold
Q1 2025 98.47K $13.06M Add
Q2 2025 94.97K $12.92M Reduce
Q3 2025 93.97K $12.59M Reduce
Q4 2025 92.40K $11.58M Reduce
Q1 2026 65.25K $6.70M Reduce
Q2 2026 69.24K $6.28M Add
Q3 2026 69.61K $6.88M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Ascent Wealth Partners, LLC held ABT?

Ascent Wealth Partners, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Ascent Wealth Partners, LLC's current position in ABT?

As of Q3 2026, Ascent Wealth Partners, LLC holds 69.61K shares of ABT (ABBOTT LABORATORIES), valued at $6.88M, representing 0.68% of its reported portfolio and ranking #46.

Has Ascent Wealth Partners, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Ascent Wealth Partners, LLC increased its position in ABT. The position peaked in Q1 2025 at 98.47K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.